Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA)Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

Part of a CDC inforgraphic on MIS-C based on reports from U.S. cases March-May 2020.[2] The full inforgraphic can be found at https://www.cdc.gov/coronavirus/2019-ncov/covid-data/infographic-mis-c.html #COVID19

Part of a CDC inforgraphic on MIS-C based on reports from U.S. cases March-May 2020.[2] The full inforgraphic can be found at https://www.cdc.gov/coronavirus/2019-ncov/covid-data/infographic-mis-c.html

News | Coronavirus (COVID-19) | August 07, 2020
August 7, 2020 — The National Institutes of Health (NIH) announced research funding to encourage the development of...
Abiomed Impella is now authorized to treat critical ICU COVID-19 patients on ECMO who develop pulmonary edema or need cardiac decompensation from myocarditis. #COVID19 #SARScov2 #Impella

Abiomed Impella is now authorized to treat critical ICU COVID-19 patients on ECMO who develop pulmonary edema or need cardiac decompensation from myocarditis.

Feature | Coronavirus (COVID-19) | August 05, 2020 | Dave Fornell, Editor
August 5, 2020 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) this week for...
Left, a 3-D rendering of a heart from a cardiac CT exam. Right, a lung-CT exam showing the heart and ground glass lesions in the lungs of a COVID-19 patient. CT has become a front-line imaging modality in the COVID era because it offers both cardiac and lung information to help determine a patients disposition with chest pain, COVID-19 and COVID-caused myocarditis and pulmonary embolism.

Left, a 3-D rendering of a heart from a cardiac CT exam. Right, a lung-CT exam showing the heart and ground glass lesions in the lungs of a COVID-19 patient. CT has become a front-line imaging modality in the COVID era because it offers both cardiac and lung information to help determine a patients disposition with chest pain, COVID-19 and COVID-caused myocarditis and pulmonary embolism.

Feature | Coronavirus (COVID-19) | July 28, 2020 | Dave Fornell, Editor
July 28, 2020 — The use of cardiovascular computed tomography angiography (CCTA) is one of the areas that has seen a...
Videos | EP Lab | July 28, 2020
Devi G. Nair, M.D., FHRS, director of cardiac electrophysiology, St. Bernards Heart and Vascular Center, Jonesboro, Ark...
Figure B — Top panel, neutrophils noted in collections within small vessels (blue arrow), plump endothelial cells (yellow arrowhead) and a single perivascular dying myocyte (blue arrowhead). Bottom panel, single myocyte undergoing degeneration (blue arrowhead) and plump endothelial cell (yellow arrowhead). Figure C — Electron microscopy, showing particles of SARS-CoV-2 virus present within a cardiac endothelial cell (blue arrowheads), but not present in neighboring cardiac myocyte. #COVID19

Figure B — Top panel, neutrophils noted in collections within small vessels (blue arrow), plump endothelial cells (yellow arrowhead) and a single perivascular dying myocyte (blue arrowhead). Bottom panel, single myocyte undergoing degeneration (blue arrowhead) and plump endothelial cell (yellow arrowhead). Figure C — Electron microscopy, showing particles of SARS-CoV-2 virus present within a cardiac endothelial cell (blue arrowheads), but not present in neighboring cardiac myocyte (left side of image). Images from Circulation.

Feature | Coronavirus (COVID-19) | July 23, 2020
July 23, 2020 - A series of autopsies conducted by Louisiana State University (LSU) Health New Orleans pathologists...
The impact of COVID-19 on the healthcare industry.

Getty images

News | Coronavirus (COVID-19) | July 16, 2020
July 16, 2020 – Frost and Sullivan’s recent analysis, Post-Pandemic Global Healthcare Market Outlook, 2020, forecasts...
The American Society of Nuclear Cardiology 2020 Meeting is going Virtual Due to COVID-19. 
News | ASNC | July 15, 2020
July 15, 2020 — The American Society of Nuclear Cardiology (ASNC) 2020 meeting is going virtual due to the COVID-19...
VitalSight is a HIPAA-compliant, Medicare-reimbursable home blood pressure monitoring solution that generally comes at no cost to the patient, depending on their coverage. The kit typically includes a digital blood pressure monitor with cuff, weight scale and digital medication tracker, as well as a data hub.
News | Hypertension | July 15, 2020
July 15, 2020 – Omron Healthcare Inc. and Mount Sinai Health System, New York City’s largest academic medical system,...
Digisonics cardiovascular information system (CVIS) can be used to aid remote image and report access to reduce in-person staff interaction to aid COVID-19 containment efforts.
News | Cardiovascular Information Systems (CVIS) | July 15, 2020
July 15, 2020 – Remote image reading capabilities for cardiology and radiology providers has become increasingly...
The American Heart Association (AHA) has cancelled its in-person annual meeting due to COVID-19 and plans to host a virtual, online meeting instead.

The American Heart Association (AHA) has cancelled its in-person annual meeting due to COVID-19 and plans to host a virtual, online meeting instead.

News | AHA | July 15, 2020
July 15, 2020 – The last major cardiovascular conference to go virtual in 2020 due to the COVID-19 (SARS-Cov-2)...
Cardiac MRI for four children with clinical diagnosis of acute myocarditis in the setting of COVID-19–related Kawasaki-like symptoms of Multisystem Inflammatory Syndrome in Children (MIS-C). Cardiac MRI of COVID pediatric COVID-19 patients.

Cardiac MRI for four children with clinical diagnosis of acute myocarditis in the setting of COVID-19–related Kawasaki-like symptoms of MIS-C. The top panel demonstrates minimal pericardial effusion on cine images. The second panel demonstrates increased T2-STIR signal intensity with average ratios between myocardium and muscle > 2 in patient 2 (12-year-old male), patient 3 (11-year-old female) and patient 4 (6-year-old female). The third panel demonstrates abnormal native-T1 mapping, which was > 1,100 ms in patients 2, 3 and 4 and normal in patient 1 (8-year-old female). The bottom panel demonstrates absence of late gadolinium enhancement (LGE) in patients 2 and 3. Myocardial null times were recognized as too short in patient 4 but could not be repeated due to lack of further patient cooperation; however review of Look Locker images and additional sequences revealed no LGE. Image courtesy of RSNA.

Feature | Coronavirus (COVID-19) | July 09, 2020
July 8, 2020 — Cardiac magnetic resonance imaging (MRI) has been shown to be helpful in evaluating multisystem...
Older Critically Ill COVID-19 Patients May Have Increased Risk of Bradycardia With Lopinavir and Ritonavir.

Photo copyright American Heart Association, used with permission.

Feature | Coronavirus (COVID-19) | July 09, 2020
July 9, 2020 — Older, critically ill patients with COVID-19 (SARS-CoV-2) who received a combination of the...
Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), has been the target of threats over his suggestions on how to contain the spread of coronavirus in the U.S. Photo by Jonathan Wyett, U.S. Department of State

Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), has been the target of threats over his suggestions on how to contain the spread of coronavirus in the U.S. Photo by Jonathan Wyett, U.S. Department of State

News | Coronavirus (COVID-19) | July 07, 2020 | Dave Fornell, Editor
July 7, 2020 — In the face of the coronavirus pandemic, public health officials worldwide are working tirelessly to...
The Linq II implantable cardiac monitor (ICM) system delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. The new devices allows continuous cardiac monitoring for up to 4.5 years.

The Linq II implantable cardiac monitor (ICM) system delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. The new devices allows continuous cardiac monitoring for up to 4.5 years.

News | Implantable Cardiac Monitor (ICM) | July 07, 2020
July 7, 2020 – Medtronic announced it received U.S. Food and Drug Administration (FDA) clearance and European CE mark...
Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosai

Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosaic pattern with a bronchocentric distribution to the GGO (white arrow, d) involving both central and peripheral lung parenchyma with pleural effusions (black small arrow, d). image courtesy of Radiological Society of North America

Feature | Coronavirus (COVID-19) | June 30, 2020
In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association with prior exposure...